Gene Symbol | Gene ID | Gene Info |
---|---|---|
TEAD3
|
ENSG00000007866.14 | TEA domain transcription factor 3 |
TEAD1
|
ENSG00000187079.10 | TEA domain transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_12699704_12699855 | TEAD1 | 2729 | 0.393041 | 0.91 | 6.6e-04 | Click! |
chr11_12700850_12701050 | TEAD1 | 3900 | 0.342896 | 0.90 | 1.0e-03 | Click! |
chr11_12714851_12715219 | TEAD1 | 17985 | 0.263772 | 0.89 | 1.2e-03 | Click! |
chr11_12699867_12700018 | TEAD1 | 2892 | 0.383003 | 0.89 | 1.4e-03 | Click! |
chr11_12716517_12716689 | TEAD1 | 19553 | 0.258982 | 0.88 | 1.7e-03 | Click! |
chr6_35461620_35461771 | TEAD3 | 3032 | 0.222226 | 0.96 | 3.2e-05 | Click! |
chr6_35458145_35458450 | TEAD3 | 6430 | 0.172876 | 0.94 | 1.2e-04 | Click! |
chr6_35462234_35462385 | TEAD3 | 2418 | 0.253621 | 0.78 | 1.4e-02 | Click! |
chr6_35461948_35462198 | TEAD3 | 2654 | 0.239322 | 0.75 | 2.1e-02 | Click! |
chr6_35464012_35464267 | TEAD3 | 588 | 0.718236 | 0.72 | 3.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_64464860_64465690 | 4.09 |
RP11-4F22.2 |
|
52303 |
0.15 |
chr7_100464814_100466140 | 3.27 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr16_28549300_28549715 | 3.23 |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
822 |
0.5 |
chr10_128594807_128595039 | 2.76 |
DOCK1 |
dedicator of cytokinesis 1 |
945 |
0.64 |
chr1_1293240_1293444 | 2.69 |
MXRA8 |
matrix-remodelling associated 8 |
573 |
0.49 |
chr10_73724084_73724979 | 2.62 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
408 |
0.89 |
chrX_10587548_10588615 | 2.45 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
378 |
0.91 |
chr19_58715618_58715868 | 2.43 |
ZNF274 |
zinc finger protein 274 |
20880 |
0.11 |
chr2_36924555_36924939 | 2.40 |
VIT |
vitrin |
727 |
0.75 |
chr19_782291_783217 | 2.37 |
PTBP1 |
polypyrimidine tract binding protein 1 |
14321 |
0.09 |
chr1_86047684_86048329 | 2.34 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
1562 |
0.37 |
chr10_133759832_133759983 | 2.33 |
PPP2R2D |
protein phosphatase 2, regulatory subunit B, delta |
6374 |
0.26 |
chr5_148787363_148787711 | 2.33 |
ENSG00000208035 |
. |
20944 |
0.11 |
chr1_116088639_116088947 | 2.31 |
ENSG00000239984 |
. |
60299 |
0.11 |
chr6_5084934_5086227 | 2.28 |
PPP1R3G |
protein phosphatase 1, regulatory subunit 3G |
140 |
0.97 |
chr3_71553679_71554070 | 2.17 |
ENSG00000221264 |
. |
37366 |
0.17 |
chr12_68653261_68653622 | 2.16 |
IL22 |
interleukin 22 |
6054 |
0.23 |
chr4_19778605_19778779 | 2.15 |
SLIT2 |
slit homolog 2 (Drosophila) |
476191 |
0.01 |
chr13_99629297_99629574 | 2.15 |
DOCK9 |
dedicator of cytokinesis 9 |
809 |
0.71 |
chr10_49812202_49812558 | 2.12 |
ARHGAP22 |
Rho GTPase activating protein 22 |
617 |
0.77 |
chr8_49832237_49832502 | 2.11 |
SNAI2 |
snail family zinc finger 2 |
1619 |
0.54 |
chr15_96869088_96869239 | 2.11 |
NR2F2 |
nuclear receptor subfamily 2, group F, member 2 |
4 |
0.96 |
chr9_139222523_139222920 | 2.10 |
GPSM1 |
G-protein signaling modulator 1 |
789 |
0.52 |
chr2_206550384_206550637 | 2.09 |
NRP2 |
neuropilin 2 |
2495 |
0.4 |
chr9_35516264_35516818 | 2.08 |
RUSC2 |
RUN and SH3 domain containing 2 |
22088 |
0.14 |
chr19_45350061_45350833 | 2.06 |
PVRL2 |
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
664 |
0.57 |
chr19_18497753_18498116 | 2.06 |
ENSG00000264175 |
. |
562 |
0.48 |
chr1_113392068_113392383 | 2.06 |
SLC16A1 |
solute carrier family 16 (monocarboxylate transporter), member 1 |
86385 |
0.07 |
chr13_111863178_111863377 | 2.05 |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
5641 |
0.26 |
chr14_34111411_34111801 | 2.04 |
NPAS3 |
neuronal PAS domain protein 3 |
92841 |
0.1 |
chr7_134464463_134465343 | 2.04 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr11_123396070_123396267 | 2.03 |
GRAMD1B |
GRAM domain containing 1B |
176 |
0.97 |
chr5_167741784_167742031 | 2.02 |
WWC1 |
WW and C2 domain containing 1 |
22752 |
0.23 |
chr11_27720314_27720465 | 1.99 |
BDNF |
brain-derived neurotrophic factor |
825 |
0.7 |
chr5_37840333_37840656 | 1.98 |
GDNF |
glial cell derived neurotrophic factor |
706 |
0.76 |
chr3_125985987_125986785 | 1.96 |
ALDH1L1-AS2 |
ALDH1L1 antisense RNA 2 |
60288 |
0.1 |
chr4_139939103_139939567 | 1.96 |
ENSG00000264953 |
. |
602 |
0.65 |
chr12_72665374_72665945 | 1.95 |
ENSG00000236333 |
. |
112 |
0.93 |
chr15_34787220_34787451 | 1.94 |
ENSG00000221065 |
. |
33237 |
0.14 |
chr6_132437024_132437191 | 1.93 |
ENSG00000265669 |
. |
704 |
0.8 |
chr3_64253622_64253921 | 1.91 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
116 |
0.98 |
chr3_112359594_112359745 | 1.91 |
CCDC80 |
coiled-coil domain containing 80 |
447 |
0.87 |
chr11_43597772_43598095 | 1.91 |
ENSG00000199077 |
. |
5011 |
0.24 |
chr10_134778652_134778938 | 1.90 |
TTC40 |
tetratricopeptide repeat domain 40 |
22468 |
0.22 |
chr8_32085203_32085460 | 1.89 |
NRG1-IT2 |
NRG1 intronic transcript 2 (non-protein coding) |
6887 |
0.22 |
chr5_174162455_174162926 | 1.89 |
MSX2 |
msh homeobox 2 |
11085 |
0.25 |
chr7_143579813_143580255 | 1.82 |
FAM115A |
family with sequence similarity 115, member A |
36 |
0.98 |
chr16_4424352_4424847 | 1.81 |
VASN |
vasorin |
2750 |
0.17 |
chr6_53918755_53918914 | 1.80 |
MLIP-AS1 |
MLIP antisense RNA 1 |
6442 |
0.23 |
chr20_30196082_30196710 | 1.79 |
ENSG00000264395 |
. |
1407 |
0.28 |
chrX_106898289_106898771 | 1.79 |
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
15942 |
0.22 |
chr15_96881380_96881711 | 1.75 |
ENSG00000222651 |
. |
5055 |
0.17 |
chr10_11594471_11594698 | 1.74 |
USP6NL |
USP6 N-terminal like |
20310 |
0.24 |
chr11_32194330_32194721 | 1.74 |
RP1-65P5.3 |
|
67888 |
0.1 |
chr22_31226381_31226720 | 1.72 |
OSBP2 |
oxysterol binding protein 2 |
8047 |
0.21 |
chr5_180212623_180213033 | 1.72 |
CTC-205M6.5 |
|
2041 |
0.28 |
chr9_13139775_13140080 | 1.70 |
MPDZ |
multiple PDZ domain protein |
3747 |
0.37 |
chr1_156645683_156645995 | 1.68 |
NES |
nestin |
1350 |
0.25 |
chr1_43672843_43673024 | 1.67 |
ENSG00000199240 |
. |
10845 |
0.14 |
chr7_27188440_27188721 | 1.67 |
HOXA-AS3 |
HOXA cluster antisense RNA 3 |
1091 |
0.19 |
chr16_31464634_31465197 | 1.66 |
ARMC5 |
armadillo repeat containing 5 |
4486 |
0.1 |
chr6_4351800_4352138 | 1.66 |
ENSG00000201185 |
. |
76228 |
0.11 |
chr12_107975208_107975572 | 1.65 |
BTBD11 |
BTB (POZ) domain containing 11 |
963 |
0.6 |
chr8_96079099_96079290 | 1.65 |
MIR3150A |
microRNA 3150a |
5954 |
0.16 |
chr10_29824157_29824642 | 1.64 |
ENSG00000207612 |
. |
9627 |
0.19 |
chr1_39880006_39880255 | 1.64 |
MACF1 |
microtubule-actin crosslinking factor 1 |
58 |
0.97 |
chr12_89845524_89845923 | 1.63 |
POC1B |
POC1 centriolar protein B |
45311 |
0.13 |
chr18_3623870_3624050 | 1.62 |
DLGAP1-AS2 |
DLGAP1 antisense RNA 2 |
20224 |
0.15 |
chr16_3481535_3482301 | 1.62 |
ZNF597 |
zinc finger protein 597 |
11624 |
0.11 |
chr3_194014374_194014621 | 1.61 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
57550 |
0.12 |
chr11_119208113_119208343 | 1.61 |
RP11-334E6.10 |
|
209 |
0.85 |
chr6_135230254_135230449 | 1.61 |
ALDH8A1 |
aldehyde dehydrogenase 8 family, member A1 |
19948 |
0.21 |
chr1_86046643_86047495 | 1.60 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
625 |
0.71 |
chr18_421335_421729 | 1.60 |
RP11-720L2.2 |
|
2884 |
0.33 |
chr3_93895824_93896204 | 1.58 |
ENSG00000253062 |
. |
78604 |
0.1 |
chr17_16389894_16390114 | 1.58 |
FAM211A |
family with sequence similarity 211, member A |
5328 |
0.18 |
chr9_73483972_73484180 | 1.57 |
TRPM3 |
transient receptor potential cation channel, subfamily M, member 3 |
102 |
0.98 |
chr2_178261408_178261672 | 1.57 |
AGPS |
alkylglycerone phosphate synthase |
4044 |
0.17 |
chr11_10695962_10696877 | 1.56 |
MRVI1 |
murine retrovirus integration site 1 homolog |
18642 |
0.17 |
chr7_55253774_55253939 | 1.56 |
EGFR-AS1 |
EGFR antisense RNA 1 |
2771 |
0.38 |
chr13_33759866_33760149 | 1.55 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
209 |
0.95 |
chr12_127630211_127630625 | 1.55 |
ENSG00000239776 |
. |
20254 |
0.29 |
chr3_49170609_49171370 | 1.54 |
LAMB2 |
laminin, beta 2 (laminin S) |
438 |
0.69 |
chr1_226373050_226373207 | 1.53 |
ACBD3 |
acyl-CoA binding domain containing 3 |
1303 |
0.44 |
chr8_89340038_89340774 | 1.53 |
MMP16 |
matrix metallopeptidase 16 (membrane-inserted) |
152 |
0.73 |
chr7_98734981_98735368 | 1.52 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
6468 |
0.25 |
chr2_230135388_230135942 | 1.52 |
PID1 |
phosphotyrosine interaction domain containing 1 |
316 |
0.93 |
chr5_39256346_39256727 | 1.51 |
FYB |
FYN binding protein |
14210 |
0.27 |
chr6_83073110_83073416 | 1.51 |
TPBG |
trophoblast glycoprotein |
85 |
0.98 |
chr17_79393172_79393543 | 1.51 |
RP11-1055B8.7 |
BAH and coiled-coil domain-containing protein 1 |
12039 |
0.11 |
chr20_39701187_39701437 | 1.50 |
TOP1 |
topoisomerase (DNA) I |
43854 |
0.14 |
chr13_30077254_30077675 | 1.48 |
MTUS2-AS1 |
MTUS2 antisense RNA 1 |
13222 |
0.26 |
chr12_26379464_26379833 | 1.48 |
SSPN |
sarcospan |
31042 |
0.17 |
chr3_87039220_87039752 | 1.47 |
VGLL3 |
vestigial like 3 (Drosophila) |
366 |
0.93 |
chr17_46970773_46971045 | 1.46 |
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
234 |
0.87 |
chr3_192568317_192568648 | 1.46 |
MB21D2 |
Mab-21 domain containing 2 |
67468 |
0.12 |
chr3_98680793_98681216 | 1.46 |
ENSG00000207331 |
. |
53701 |
0.13 |
chr4_170188382_170188561 | 1.45 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2637 |
0.38 |
chr5_37838881_37839090 | 1.44 |
GDNF |
glial cell derived neurotrophic factor |
797 |
0.72 |
chrX_129253047_129253534 | 1.44 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
8599 |
0.2 |
chr6_35490530_35490700 | 1.44 |
TULP1 |
tubby like protein 1 |
9900 |
0.18 |
chr2_65889672_65889956 | 1.43 |
ENSG00000265899 |
. |
4576 |
0.32 |
chr5_158611818_158612659 | 1.41 |
RNF145 |
ring finger protein 145 |
22404 |
0.16 |
chr17_70113280_70113463 | 1.40 |
SOX9 |
SRY (sex determining region Y)-box 9 |
3790 |
0.36 |
chr17_52978401_52978600 | 1.40 |
TOM1L1 |
target of myb1 (chicken)-like 1 |
5 |
0.99 |
chr5_32713152_32713703 | 1.39 |
NPR3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
990 |
0.65 |
chr12_109246535_109246783 | 1.39 |
SSH1 |
slingshot protein phosphatase 1 |
4700 |
0.17 |
chr6_151563077_151563228 | 1.38 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
1643 |
0.31 |
chr2_232276665_232277472 | 1.38 |
B3GNT7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
16814 |
0.12 |
chr10_128771641_128771806 | 1.38 |
RP11-223P11.3 |
|
52963 |
0.15 |
chr16_23508784_23509063 | 1.37 |
GGA2 |
golgi-associated, gamma adaptin ear containing, ARF binding protein 2 |
12787 |
0.14 |
chr7_40866718_40867078 | 1.36 |
AC005160.3 |
|
51741 |
0.19 |
chr4_186760553_186760777 | 1.36 |
SORBS2 |
sorbin and SH3 domain containing 2 |
26387 |
0.22 |
chr1_78353984_78354259 | 1.36 |
NEXN |
nexilin (F actin binding protein) |
77 |
0.93 |
chr6_43739856_43740457 | 1.36 |
VEGFA |
vascular endothelial growth factor A |
427 |
0.79 |
chr3_147016231_147016401 | 1.34 |
RP11-649A16.1 |
|
72127 |
0.11 |
chr4_188049686_188049901 | 1.34 |
ENSG00000252382 |
. |
271183 |
0.02 |
chr1_120191467_120191618 | 1.33 |
ZNF697 |
zinc finger protein 697 |
1146 |
0.52 |
chr5_33148047_33148451 | 1.32 |
CTD-2203K17.1 |
|
292476 |
0.01 |
chr8_65488422_65488732 | 1.32 |
RP11-21C4.1 |
|
1243 |
0.52 |
chr6_114182367_114182913 | 1.32 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
4099 |
0.23 |
chr5_38846105_38846894 | 1.31 |
OSMR |
oncostatin M receptor |
398 |
0.91 |
chr2_107503478_107503965 | 1.31 |
ST6GAL2 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 |
157 |
0.97 |
chr14_85707273_85707789 | 1.30 |
ENSG00000252529 |
. |
30745 |
0.26 |
chr12_80081544_80081908 | 1.30 |
PAWR |
PRKC, apoptosis, WT1, regulator |
2134 |
0.41 |
chr7_111720888_111721301 | 1.30 |
DOCK4 |
dedicator of cytokinesis 4 |
76908 |
0.11 |
chr19_49371270_49371506 | 1.29 |
PLEKHA4 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
323 |
0.76 |
chr11_125364841_125365435 | 1.29 |
AP000708.1 |
|
28 |
0.88 |
chr14_100197072_100197259 | 1.27 |
EML1 |
echinoderm microtubule associated protein like 1 |
6865 |
0.22 |
chr5_155108288_155108670 | 1.27 |
ENSG00000200275 |
. |
163968 |
0.04 |
chr8_94934276_94934427 | 1.26 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
2244 |
0.3 |
chr17_6478459_6478679 | 1.26 |
PITPNM3 |
PITPNM family member 3 |
18755 |
0.13 |
chr13_114611230_114611463 | 1.25 |
GAS6 |
growth arrest-specific 6 |
44300 |
0.17 |
chr5_178367547_178367761 | 1.25 |
ZNF454 |
zinc finger protein 454 |
538 |
0.73 |
chr17_15165187_15165338 | 1.25 |
PMP22 |
peripheral myelin protein 22 |
571 |
0.56 |
chr6_26735274_26735490 | 1.25 |
ZNF322 |
zinc finger protein 322 |
75402 |
0.09 |
chr2_223621313_223621464 | 1.24 |
ENSG00000238852 |
. |
58669 |
0.12 |
chr3_189508446_189508597 | 1.24 |
TP63 |
tumor protein p63 |
931 |
0.69 |
chr1_242097620_242097936 | 1.23 |
EXO1 |
exonuclease 1 |
55436 |
0.13 |
chr6_142696311_142696678 | 1.23 |
GPR126 |
G protein-coupled receptor 126 |
14955 |
0.28 |
chr2_190042287_190042516 | 1.23 |
COL5A2 |
collagen, type V, alpha 2 |
2204 |
0.37 |
chr8_48572289_48573010 | 1.23 |
SPIDR |
scaffolding protein involved in DNA repair |
423 |
0.86 |
chr21_43537496_43537668 | 1.23 |
C21orf128 |
chromosome 21 open reading frame 128 |
8938 |
0.21 |
chr10_112096180_112096531 | 1.22 |
SMNDC1 |
survival motor neuron domain containing 1 |
31646 |
0.19 |
chr11_72500561_72500812 | 1.22 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
3674 |
0.14 |
chr9_130607326_130607477 | 1.22 |
ENSG00000222455 |
. |
3900 |
0.09 |
chr22_40930275_40930426 | 1.21 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
535 |
0.76 |
chr2_133110293_133110524 | 1.21 |
ENSG00000252705 |
. |
54023 |
0.13 |
chr12_64239539_64239880 | 1.21 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
1168 |
0.42 |
chr22_37956672_37957106 | 1.21 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
402 |
0.77 |
chr6_28603024_28603495 | 1.20 |
ENSG00000272278 |
. |
12783 |
0.2 |
chr18_55881104_55881255 | 1.20 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
7588 |
0.24 |
chr6_26766570_26766929 | 1.20 |
GUSBP2 |
glucuronidase, beta pseudogene 2 |
79868 |
0.09 |
chr2_18654617_18654910 | 1.19 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
87183 |
0.09 |
chr14_81462531_81462713 | 1.19 |
CEP128 |
centrosomal protein 128kDa |
36774 |
0.19 |
chr6_56573707_56573932 | 1.19 |
DST |
dystonin |
66025 |
0.13 |
chr6_18023074_18023308 | 1.19 |
KIF13A |
kinesin family member 13A |
35337 |
0.2 |
chr4_69138068_69138418 | 1.19 |
TMPRSS11B |
transmembrane protease, serine 11B |
26805 |
0.16 |
chr3_65837494_65837757 | 1.18 |
MAGI1-AS1 |
MAGI1 antisense RNA 1 |
41866 |
0.18 |
chr17_4902045_4902282 | 1.18 |
KIF1C |
kinesin family member 1C |
914 |
0.26 |
chr5_178506733_178506884 | 1.17 |
ZNF354C |
zinc finger protein 354C |
19392 |
0.2 |
chr5_169406944_169407149 | 1.17 |
FAM196B |
family with sequence similarity 196, member B |
698 |
0.77 |
chr7_47419663_47419875 | 1.17 |
TNS3 |
tensin 3 |
73060 |
0.13 |
chr1_156630677_156631393 | 1.16 |
RP11-284F21.7 |
|
181 |
0.89 |
chrX_34673071_34673254 | 1.16 |
TMEM47 |
transmembrane protein 47 |
2243 |
0.48 |
chr16_67279663_67280216 | 1.16 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
879 |
0.31 |
chr14_99684836_99684987 | 1.15 |
AL109767.1 |
|
44374 |
0.15 |
chr8_22104509_22104660 | 1.15 |
POLR3D |
polymerase (RNA) III (DNA directed) polypeptide D, 44kDa |
1836 |
0.21 |
chr6_49293859_49294324 | 1.15 |
ENSG00000252457 |
. |
18430 |
0.26 |
chr15_71984232_71984427 | 1.15 |
CTD-2524L6.3 |
|
126408 |
0.05 |
chr5_142024845_142025009 | 1.14 |
FGF1 |
fibroblast growth factor 1 (acidic) |
1161 |
0.51 |
chr22_33199513_33199664 | 1.14 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
1901 |
0.4 |
chr9_18474095_18474958 | 1.14 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr3_42948291_42948473 | 1.14 |
ZNF662 |
zinc finger protein 662 |
724 |
0.58 |
chr7_150810548_150810738 | 1.14 |
AGAP3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
1122 |
0.34 |
chr20_46013102_46013262 | 1.14 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
27615 |
0.13 |
chr12_15907715_15907866 | 1.14 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
25871 |
0.23 |
chr1_92202384_92202604 | 1.13 |
ENSG00000239794 |
. |
93137 |
0.08 |
chr2_216401222_216401388 | 1.13 |
AC012462.1 |
|
100329 |
0.08 |
chr5_138466969_138467149 | 1.13 |
SIL1 |
SIL1 nucleotide exchange factor |
388 |
0.88 |
chr6_121759244_121759464 | 1.13 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
2516 |
0.27 |
chr16_24682174_24682612 | 1.13 |
TNRC6A |
trinucleotide repeat containing 6A |
58623 |
0.14 |
chr22_25346267_25346418 | 1.13 |
KIAA1671 |
KIAA1671 |
2355 |
0.29 |
chr17_39957615_39957959 | 1.13 |
LEPREL4 |
leprecan-like 4 |
10025 |
0.09 |
chr12_119617594_119617745 | 1.13 |
HSPB8 |
heat shock 22kDa protein 8 |
274 |
0.89 |
chr4_41157110_41157449 | 1.13 |
ENSG00000207198 |
. |
41320 |
0.14 |
chr7_134465998_134466492 | 1.12 |
CALD1 |
caldesmon 1 |
1816 |
0.49 |
chr8_127837007_127837644 | 1.12 |
ENSG00000212451 |
. |
153558 |
0.04 |
chr17_48912225_48912411 | 1.12 |
WFIKKN2 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
307 |
0.87 |
chr7_134396917_134397381 | 1.12 |
CALD1 |
caldesmon 1 |
31854 |
0.2 |
chr9_22005601_22005829 | 1.11 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
3237 |
0.19 |
chr2_16804457_16804907 | 1.11 |
FAM49A |
family with sequence similarity 49, member A |
338 |
0.94 |
chr7_42036090_42036365 | 1.11 |
GLI3 |
GLI family zinc finger 3 |
231093 |
0.02 |
chr17_773364_773548 | 1.11 |
NXN |
nucleoredoxin |
6105 |
0.16 |
chr8_97536070_97536353 | 1.11 |
SDC2 |
syndecan 2 |
29975 |
0.22 |
chr10_114714851_114715858 | 1.11 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr12_33054724_33054875 | 1.11 |
PKP2 |
plakophilin 2 |
5025 |
0.32 |
chr12_58758249_58758400 | 1.10 |
RP11-362K2.2 |
Protein LOC100506869 |
179583 |
0.03 |
chr17_36610454_36610862 | 1.10 |
ENSG00000260833 |
. |
1970 |
0.27 |
chr16_49677980_49678248 | 1.10 |
ZNF423 |
zinc finger protein 423 |
3351 |
0.32 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.9 | 2.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 2.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 1.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 1.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.5 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 0.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 1.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 4.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 1.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 1.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 1.5 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.8 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 2.9 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.3 | 0.8 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 1.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.9 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.2 | 1.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.6 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.2 | 4.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.2 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 1.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.8 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.6 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.9 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.4 | GO:0090504 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.9 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.1 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.1 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.5 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.8 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.4 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.5 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 1.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.4 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.3 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 1.3 | GO:0071456 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.6 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.1 | GO:0060087 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 0.3 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 1.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.5 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 2.4 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.4 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.8 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.6 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.4 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.8 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 0.3 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.2 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 1.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.4 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 1.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 1.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.8 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.8 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.1 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.1 | 0.1 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.1 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.4 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 1.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.1 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.7 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.3 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.1 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.1 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0048668 | collateral sprouting(GO:0048668) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.3 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.4 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0001743 | optic placode formation(GO:0001743) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.3 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0060581 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 1.3 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.0 | 0.7 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.4 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 4.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 1.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.7 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.2 | GO:0051956 | negative regulation of organic acid transport(GO:0032891) negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 1.2 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.4 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.6 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 1.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
0.0 | 0.0 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.4 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0098926 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.2 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.0 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:2000756 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
0.0 | 0.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.3 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.0 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 1.9 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0032692 | negative regulation of interleukin-1 beta production(GO:0032691) negative regulation of interleukin-1 production(GO:0032692) |
0.0 | 0.0 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0019748 | secondary metabolic process(GO:0019748) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.5 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 0.0 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.0 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.0 | 0.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.0 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 1.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.4 | 1.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 0.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 1.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 3.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.5 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 3.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 2.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 2.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 3.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 3.6 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 13.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.0 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.6 | GO:0030131 | clathrin coat(GO:0030118) clathrin adaptor complex(GO:0030131) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 4.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.5 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 2.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 2.3 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 1.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.1 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 1.1 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.0 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.6 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.6 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.5 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 3.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 2.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.7 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 2.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 2.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 1.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 3.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 4.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 1.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.0 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 4.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 2.8 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.2 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
0.0 | 1.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 1.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 2.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 6.6 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 8.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 2.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 5.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.3 | 3.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 4.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 2.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |